Press releases | Finanzwire

Basculer en Français

10387	Companies
216918	Keywords
146616	Articles
114860	Press releases

Home
Press releases

PRESS RELEASE

published on 03/27/2025 at 18:00, 1 year 1 month ago

Following decisive advances and a significant improvement in its results in 2024, Amoéba is approaching 2025 with confidence and is getting closer to commercialising its first products
Amoéba achieves significant milestones in 2024, including strategic partnerships, financial improvements, and advancements in biocontrol and cosmetics. Financial statements show positive growth

AMOEBA Financial Statements Partnerships Biocontrol Cosmetics
PRESS RELEASE

published on 03/27/2025 at 18:00, 1 year 1 month ago

Continued profitable growth and strong cash generation at the end of fiscal 2024
EPC Groupe's FY 2024 results: Sales up 3.2%, EBITDA up 2.1%, free cash flow €40.0M. Proposed dividend of 1.50 € per share

Financial Results EBITDA Dividend EPC Groupe FY 2024
PRESS RELEASE

published on 03/27/2025 at 18:00, 1 year 1 month ago

FIRST-HALF 2024/25 RESULTS
Eagle Football Group's Board of Directors approves the 2024/2025 interim financial statements reflecting revenues from business activities, player trading, and cost-cutting measures

Financial Statements Revenue Cost-cutting Player Trading Eagle Football Group
PRESS RELEASE

published on 03/27/2025 at 18:00, 1 year 1 month ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received an amended transparency notification from Atlas Special Opportunities II, LLC regarding the sale of voting securities. This press release replaces the one from March 18, 2025

Transparency Notification Euronext Brussels Oxurion NV Retinal Disease Therapies Atlas Special Opportunities II
PRESS RELEASE

published on 03/27/2025 at 17:47, 1 year 1 month ago

Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc purchases 243,065 Ordinary Shares for cancellation. Highest price: 120.00p, Lowest price: 117.00p. Company's issued share capital: 317,798,217 shares

London Stock Exchange Ordinary Shares Share Buyback Programme Funding Circle Plc Investec Bank
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 1 month ago

SAF-HOLLAND sets new medium-term targets with the 'drive2030' corporate strategy – Group sales expected to increase by more than 50% to over EUR 3,000 million
SAF-HOLLAND presents 'drive2030' strategy at Capital Markets Day, targeting over €3bn in sales & 10-12% EBIT margin by 2030. Focus on growth, efficiency, and sustainability

Sales Growth Strategy Capital Markets Day SAF-HOLLAND Drive2030
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 1 month ago

DKSH’s 92nd Annual General Meeting 2025
DKSH's 92nd Annual General Meeting 2025: Shareholders approve dividend increase to CHF 2.35 per share. Reelection of Board members and new appointment. Total of 166 shareholders present

Annual General Meeting Shareholders Dividend Increase DKSH Réélection
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 1 month ago

2024 Annual Results: Strong Growth and Exceptional Improvement Across All Profitability Indicators
STIF (FR001400MDW2, ALSTI) reports strong growth and exceptional improvement in all profitability indicators in 2024. Revenue up by 72.7% driven by BESS activity. Plans for further growth, product diversification, and geographical expansion in 2025

Revenue Growth Geographical Expansion STIF BESS 2024 Financial Results
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 1 month ago

Inside Information / Other news releases
Verallia releases its 2024 Universal Registration Document filing with the AMF in ESEF format. Document accessible on Verallia's and AMF's websites, containing financial and governance reports as well as sustainability information

Sustainability AMF ESEF Format Verallia 2024 Universal Registration Document
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 1 month ago

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ? Strong Outlook for 2025
Transgene achieves key milestones in 2024, including clinical proof of principle for individualized cancer vaccine TG4050, with strong outlook for 2025. New trial planned in Q4 2025 for a second indication

Milestones Cancer Vaccine Transgene 2025 Outlook Clinical Proof

Accesswire

Published on 05/12/2026 at 23:35, 9 minutes ago

Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 1 hour 49 minutes ago

UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 2 hours 2 minutes ago

Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 9 hours 14 minutes ago

Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 14:30, 9 hours 14 minutes ago

ACCESS Newswire Reports First Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 05/12/2026 at 22:25, 1 hour 18 minutes ago

Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 3 hours 22 minutes ago

Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 4 hours 8 minutes ago

AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 4 hours 9 minutes ago

2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:46, 4 hours 57 minutes ago

LION E-Mobility Reports Q1 Results and Confirms Fiscal 2026 Outlook

Les Echos

Published on 05/12/2026 at 18:15, 5 hours 29 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 5 hours 34 minutes ago

imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:45, 5 hours 59 minutes ago

imerys-12-05-2026-regulated-information-publication-of-the-report-on-payments-made-to-governments
Published on 05/12/2026 at 17:45, 5 hours 59 minutes ago

Financial information for the period ended 31 March 2026
Published on 05/12/2026 at 17:40, 6 hours 4 minutes ago

Eiffage acquires a majority stake in Hand & Werk to expand its presence in the German data centre market

View all LES ECHOS COMFI WIRE